Overview

Phase 4 IOP Signals Associated With ILUVIEN®

Status:
Unknown status
Trial end date:
2020-01-01
Target enrollment:
Participant gender:
Summary
This study will assess the safety in patients treated with ILUVIEN, with primary focus on IOP.
Phase:
Phase 4
Details
Lead Sponsor:
Alimera Sciences
Treatments:
Fluocinolone Acetonide